期刊文献+

胰岛素和格列齐特对糖尿病大鼠肝脏内质网应激和胰岛素敏感性的影响 被引量:4

The effects of insulin and gliclazide therapy on endoplasmic reticulum stress and insulin sensitivity in liver of type 2 diabetic rats
原文传递
导出
摘要 目的探讨胰岛素和格列齐特对2型糖尿病大鼠肝脏内质网应激和胰岛素敏感性的影响。方法高脂饮食联合链脲佐菌素建立2型糖尿病大鼠模型,随机分为糖尿病组、胰岛素组和格列齐特组并设正常对照组。胰岛素组和格列齐特组分别予以中效胰岛素和格列齐特治疗3周。检测肝脏免疫球蛋白结合蛋白(Bip)、剪切的x盒结合蛋白1(XBP-1s)、磷酸化c-Jun(p-c-Jun)、丝氨酸磷酸化胰岛素受体底物1(p-IRS-1)、葡萄糖6磷酸酶(G6Pase)蛋白表达。结果与正常对照组比较,糖尿病组Bip(0.28-4-0.07比0.90±0.10)、XBP-1s(0.41±O.07比0.95±0.07)、p-c-Jun(0.59±0.18比1.94±0.03)、p-IRS-1(1.73±0.18比5.324-0.22)和G6Pase(0.11±0.01比0.45±0.01)表达均增加,P值均〈0.01。胰岛素和格列齐特治疗后,与糖尿病组比较,胰岛素组和格列齐特组Bip(0.90±0.10比0.25±0.04和0.53±0.02,P值均〈0.01)、XBP-1s(0.95±0.07比0.47±0.01和0.78±0.02,P〈0.01和P〈0.05)、P-c-Jun(1.94±0.03比0.50±0.10和1.33±-O.11,P值均〈0.01)、p-IRS-1(5.32±0.22比1.59±0.32和3.13±0.02,P值均〈0.01)以及G6Pase蛋白(0.45±0.01比0.15±0.02和0.25±0.01,P值均〈0.01)表达均下降,以胰岛素组下降更明显(P值均〈0.01)。结论胰岛素和格列齐特均能减轻肝脏内质网应激、下调c-Jun氨基端激酶活性以及改善胰岛素敏感性;以胰岛素的效应更强,提示除了降糖以外,胰岛素可能还有抗炎、抗氧化应激或促使脂质重分布等作用。 Objective To investigate the effect of insulin and gliclazide therapy on endoplasmic reticulum (ER) stress and insulin sensitivity in the liver of type 2 diabetic rats. Methods A high fat diet plus a low-dose of streptozotoein was implemented to create a type 2 diabetic rats which were randomly divided into diabetes mellitus (DM) group, insulin treatment (INS) group and gliclazide treatment (GT) group; and healthy rats were as normal control group. Diabetic rats in INS and GT groups were given neutral protamine hagedorn ( NPH ) insulin and gliclazide respectively for 3 weeks. Protein expression levels of immunoglobulin binding protein (Bip), spliced X-box binding protein 1 (XBP-ls), phosphorylated c-Jun on serine 73 (p-c-Jun), phosphorylated insulin receptor substrate 1 on serine 307 (p-IRS-1), and glucose- 6-phosphatase (G6Pase) in liver homogenate were detected by Western blotting. Results Compared with the normal rats, Bip and XBP-ls in the DM group were up-regulated (0. 28±0. 07 vs 0. 90±0. 10 for Bip; O. 41±0. 07 vs 0. 95±0. 07 for XBP-ls; both P 〈0. 01 ) ; p-c-Jun (0. 59±0. 18 vs 1.94±0. 03), p-IRS-1 (1.73±0. 18 vs 5.32±0. 22 ) and G6Pase(0. 11±0. 01 vs 0. 45±0. 01 ) were increased (all P values 〈 0. 01 ). In the INS group, all of aforementioned changes were reversed (0. 90±0. 10 vs 0. 25±0. 04 for Bip; 0.95±0.07 vs 0.47±0.01 for XBP-ls; 1.94±0.03 vs 0.50±0. 10 for p-c-Jun; 5.32±0.22 vs1.59±0. 32 for p-IRS-1 ; 0.45± 0. 01 vs 0. 15 + 0. 02 for G6Pase, all P values 〈 0. 01 ). In the GT group, all of aforementioned changes were also attenuated (0. 90±0. 10 vs 0. 53±0. 02 for Bip; 0. 95±0. 07 vs 0.78+0.02 for XBP-ls; 1.94±0.03 vs 1.33±0. 11 for p-c-Jun; 5.32±0.22 vs 3.13±0.02 for p-IRS-1; 0.45±0.01 vs 0.25±0.01 for G6Pase, all P values 〈 0.05) . Furthermore, all of aforementioned protein levels were down-regulated more obviously in the INS group comparing to the GT group ( all P values 〈 0.01 ). Conclusions Both insulin and gliclazide therapy could relieve ER stress and c-Jun N-terminal kinase activity and improved insulin sensitivity. The effect of insulin on Bip, XBP-1 s, p-c-Jun, p-IRS-1 and G6Pase protein expressions is more obvious than that of glilcazide, which indicates besides lowering glucose, insulin might have protective effects of anti-inflammation, anti-oxidative stress or stimulation of lioid redistribution.
出处 《中华内科杂志》 CAS CSCD 北大核心 2012年第8期638-641,共4页 Chinese Journal of Internal Medicine
基金 国家重点基础研究发展计划基金
关键词 胰岛素 糖尿病 2型 内质网 应激 胰岛素敏感性 Insulin Diabetes mellitus, type 2 Endoplasmic reticulum Stress Insulinsensitivity
  • 相关文献

参考文献15

  • 1Ozcan U, Cao Q, Yilmaz E, et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science, 2004, 306:457-461.
  • 2Ozcan U, Yilmaz E, Ozcan L, et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science, 2006,313:1137-1140.
  • 3Weng J, Li Y, Xu W, et al. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet, 2008, 371:1753-1760.
  • 4Li Y, Xu W, Liao Z, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function. Diabetes Care, 2004, 27: 2597-2602.
  • 5Andrews WJ, Vasquez B, Nagulesparan M, et al. Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal. Diabetes, 1984, 33: 634-642.
  • 6Matthaei S, Stumvoll M, Kellerer M, et al. Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev, 2000, 21: 585-618.
  • 7毕艳,孙卫平,翁建平.初发2型糖尿病病人短期强化胰岛素治疗胰岛素抵抗改善的可能机制[J].中华医学杂志,2007,87(18):1284-1286. 被引量:38
  • 8Werstuck GH, Khan MI, Femia G, et al. Glucosamine-induced endoplasmic reticulum dysfunction is associated with accelerated atherosclerosis in a hyperglycemic mouse model. Diabetes, 2006, 55: 93-101.
  • 9Wang D, Wei Y, Pagliassotti MJ. Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology, 2006,147:943-951.
  • 10Wei Y, Wang D, Topczewski F, et al. Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am J Physiol Endocrinol Metab, 2006, 291: E275-281.

二级参考文献75

  • 1李延兵,廖志红,许雯,姚斌,邓婉萍,欧香忠,胡国亮,翁建平.胰岛素泵治疗对初诊2型糖尿病患者糖脂代谢的影响[J].中山大学学报(医学科学版),2004,25(4):359-363. 被引量:40
  • 2陈璐璐,王咏波,周慜,王保平.Effects of Insulin Treatment on Intracellular Lipid Metabolism in Liver of Diabetic Rats[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2006,26(3):284-287. 被引量:2
  • 3The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med,1993, 329:977-986.
  • 4UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet,1998, 352:837-853.
  • 5LeRoith D, Fonseca V, Vinik A. Metabolic memory in diabetes-focus on insulin. Diabetes Metab Res Rev, 2005, 21:85-90.
  • 6Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care,2006, 29:1963-1972.
  • 7Ilkova H, Glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997, 20: 1353-1356.
  • 8Li Y, Xu W, Liao Z, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function. Diabetes Care,2004, 27 : 2597-2602.
  • 9Ryan EA, Imes S, Wallace C. Short-term intensive insulin therapy in newly diagnosed type 2 diabetes. Diabetes Care,2004, 27 : 1028-1032.
  • 10Weng JP, Li YB, Xu W, et al. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes : a muhicentre randomized parallel-group trial. Lancet, 2008, 371 : 1753-1760.

共引文献66

同被引文献24

引证文献4

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部